Rapid Technological Innovations will Accelerate the Growth of Computational Medicine and Drug Discovery Market.
Browse 21 Market Tables, 47 Figures spread through 158 Pages and an in-depth TOC on “Computational Medicine and Drug Discovery Software Market – Global Forecast to 2020”.
Computational Medicine finds its roots in chemistry and quantum mechanics. The foundation of computational medicine is based upon database and constraint-based models. Database is basically repositories of information which is used in constraint-based models to understand protein-ligand interaction. With the introduction of computers, the implementation became easy. Theoretical chemistry transformed into computational chemistry and it was used to understand the interaction between biological molecules and drug.
According to recent report by IndustryARC, the computational medicine and drug discovery market is poised to grow at a CAGR of 5.1% to reach $6.78 billion by 2020. Bioinformatics has made it to possible to integrate and analyse large datasets in developing better treatment for chronic diseases such as Cancer. Predictive Analysis of Drug Targets and Disease Modelling will be the fastest growing applications.
Cloud and Mobile Platforms Provides Investment Opportunities
Information technology has been assisting the research organizations to enhance collaborative efforts, managing workflows, enabling dynamism in the processes, handling larger volumes of data and decision making. The time taken for drug discovery and development has been reduced considerably in the past two decades with the advent of fast, accurate and user friendly computational platforms. Cloud computing refers to computational platform/repository that allows remote access of large volumes of data which is available for few or more users.
The presence of data access through cloud has been gaining prominence mainly due to the involvement of several stake holders, various functional departments within the organizations in the research process. In addition, for multi-national companies which have decentralized operations; streamlining of dynamic workflows becomes difficult. Furthermore, with the research contribution becoming more globalized due to the participation of research entities from various regions, the need for common research platform is on the spotlight.
Cloud and mobile computing of software and databases forms a right solution for aforementioned needs, with focus on convenience, flexibility, remote-access and real time data. According to the industry statistics, the 83% of the health care organizations are using at least one cloud based application. Application providers have a great opportunity to enter these highly potential markets by developing new products that run on cloud and mobile platforms. In addition, they can also enhance their existing products to make them compatible with these efficient platforms to cater to the evolving needs of pharma and biotech customers.
The prominent players profiled in this report are:
- Schrodinger LLC,
- Compugen Ltd.,
- Chemical Computing Group Inc.,
- Genedata AG
- Nimbus Therapeutics Inc. along with several other companies.
- Bioinformatics Market: Product (Bioinformatics Platforms, Knowledge Management Tools, Services) Application (Proteomics, Transcriptomics, Molecular Phylogenetics, Chemoinformatics, Drug Design, Others) Sector (Drug Development, Others)-Forecast(2015-2020). http://industryarc.com/Report/10631/bioinformatics-market-analysis.html
- Magnetic Resonance Imaging Systems Market: Architecture (Closed & Open MRI Systems) Field Strength (Low-To-Mid, High, Very-High, Ultra-High Field MRI Systems) Application (Brain & Neurological MRI, Spine & Musculoskeletal MRI, Others)-Forecast(2015-2020). http://industryarc.com/Report/10605/magnetic-resonance-imaging-systems-market.html